Braeburn is a startup based in the United States, 1 tracked investor.
Braeburn is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Braeburn Pharmaceuticals develops and commercializes treatments for opioid use disorder; its lead product BRIXADI is a buprenorphine extended‑release subcutaneous injection approved by the FDA for the treatment of moderate to severe opioid use disorder.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.